Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors
- Moysiadis T.
- Baliakas P.
- Rossi D.
- Catherwood M.
- Strefford J.C.
- Delgado J.
- Anagnostopoulos A.
- Belessi C.
- Stavroyianni N.
- Pospíšilová Šárka
- Oscier D.
- Gaidano G.
- Campo E.
- Rosenquist R.
- Ghia P.
- Stamatopoulos K.
Publication date
January 2019
DOI Publisher
Springer Science and Business Media LLC Language
EnglishAbstract
Chronic lymphocytic leukemia (CLL) displays remarkable clinical heterogeneity, likely attributed to the underlying biological diversity. This claim is supported by the fact that certain immunogenetic and/or genomic features identify subgroups of CLL patients with distinct prognosis and outcome
Add to ORKG